AVBP

NASDAQStock

ArriVent BioPharma, Inc. Common Stock

$23.76-0.34 (-1.39%)

52-Week Range

$16.30
$26.56

Key Stats

Market Cap

980.8M

P/E Ratio

Dividend Yield

Beta

1.00

Volume

212.4K

Avg Volume

661.7K

Performance

1M

+7.47%

3M

+1.92%

6M

+27.15%

YTD

+15.84%

1Y

+14.74%

3Y

+20.47%

5Y

+20.47%

Price Chart

ETF Exposure

AVBP is held by 71 ETFs

ETFFund NameWeight
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About AVBP ETF Exposure

ArriVent BioPharma, Inc. Common Stock (AVBP) is held by 71 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 980.8M, AVBP is a widely held institutional stock. The stock currently trades at $23.76. Investors can gain exposure to AVBP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVBP, sorted by portfolio weight.